Alector (ALEC) Other Non-Current Liabilities (2018 - 2026)
Alector's (ALEC) quarterly Other Non-Current Liabilities came in at $1.8 million in Q1 2026, up 26.97% year-on-year from $1.4 million in Q1 2025, and up 1.9% on a QoQ basis from $1.7 million in Q4 2025.
Alector (ALEC) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Other Non-Current Liabilities data on file, last reported at $1.8 million in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 26.97% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a 26.97% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, up 40.76% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $1.8 million, up from $1.7 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for ALEC reached as high as $1.8 million in Q1 2026 and fell as low as $158000.0 in Q1 2022.
- Historically, Other Non-Current Liabilities has averaged $1.1 million across 5 years, with a median of $1.2 million in 2024.
- Across the five-year window, Other Non-Current Liabilities surged 468.35% in 2023 and dropped 10.12% in 2024, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $759000.0 in 2022, then soared by 80.9% to $1.4 million in 2023, then fell by 10.12% to $1.2 million in 2024, then jumped by 40.76% to $1.7 million in 2025, then climbed by 1.9% to $1.8 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $1.8 million in Q1 2026, $1.7 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.77 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 898,000.00 |
| Jun 30, 2023 | 898,000.00 |
| Mar 31, 2023 | 898,000.00 |
| Dec 31, 2022 | 759,000.00 |
| Sep 30, 2022 | 233,000.00 |
| Jun 30, 2022 | 233,000.00 |
| Mar 31, 2022 | 158,000.00 |
| Dec 31, 2021 | 158,000.00 |
| Sep 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 158,000.00 |